Downing LLP
VC Fund
London, United Kingdom
Downing LLP is a VC fund in London focused on Health Care and Data Center. At Downing, they aim to make a difference in the lives of their investment community. They design & manage investment products that help investors look after their financial wellbeing, while their investment partnerships support businesses in their ambitions. So far, over 35,000 investors have been a part of what they do, and they are proudto have raised and invested over £1.7 billion into businesses that make a difference, including renewable energy, care homes, health clubs, and children's nurseries.Downing is authorised and regulated by the Financial Conduct Authority.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 64%
- Fund size:
- $165M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Downing LLP invests in
Stages Downing LLP invests in
Countries Downing LLP invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 4 (36%)
- Data Center 2 (18%)
- Biotechnology 2 (18%)
- Energy 1 (9%)
- Big Data 1 (9%)
Stage
- Funding Round 4 (36%)
- Seed 1 (9%)
- Series A 1 (9%)
- Debt Financing 1 (9%)
- Post-IPO Equity 1 (9%)
Country
- United Kingdom 7 (64%)
- Australia 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dan Quin
Head of Institutional Solutions
|
Head of Institutional Solutions | Total investments: 0 | Find email | |
James Weaver
Deputy CEO & COO
|
Deputy CEO & COO | Total investments: 0 | Find email | |
Linda Bell
Non-Executive Director
|
Non-Executive Director | Total investments: 0 | Find email | |
Nick Lewis
Founder
|
Founder | Total investments: 0 | Find email | |
Oren Laufer
Director of Institutional Sales
|
Director of Institutional Sales | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cydar Medical
|
Cydar has developed computer vision software that produces real-time automated 3D overlays during X-ray guided procedures, allowing clinicians to concentrate on the patient and not on adjusting displays. High-performance overlay updates are enabled by our unique use of cloud supercomputing. | $11.3M / Series A / Feb 13, 2023 | |
Adaptix Ltd
|
Adaptix is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide. We are adding low-dose 3D capability – digital tomosynthesis - to planar X-ray while making it more affordable and truly portable so radiology can more easily travel to the patient. This transformation will enhance patient’s access tothe world’s most important imaging technologies and likely increases the diagnostic accuracy for many high incidence conditions such as cardiovascular and pulmonary diseases, lung cancer and osteoporosis. The last two decades have seen a transformation in radiology as detectors have evolved from film to digital semiconductor based devices. The next transformation will see the source switching from a single high dose acquisition to multiple very low dose acquisitions from distributed points so that more information (including 3D) can be gained from less dose. Among other benefits, the ongoing technological transformation of radiology will bring about significant cost savings. Current X-ray equipment requires a choice between high-cost 3D or lower-cost (but still expensive) 2D. All are large bulky solutions. Some are ‘moveable’ rather than truly portable. Low-cost truly portable systems based on Adaptix’ technology will allow clinicians to have easy access to 3D imaging information which can enhance the diagnostic information and likely impact patient care. Adaptix will transform radiology with its development of new Flat Panel X-ray source, a pixelated array made in a semiconductor foundry. Adaptix is harnessing a range of existing technologies, including from the space industry, and has patents filed and in process relating to both hardware and software. Companies using Adaptix products will offer 3D imaging at lower dose from smaller and lower-cost X-ray solutions. | $2M / Nov 13, 2019 | |
|
Adaptix Ltd
|
Adaptix is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide. We are adding low-dose 3D capability – digital tomosynthesis - to planar X-ray while making it more affordable and truly portable so radiology can more easily travel to the patient. This transformation will enhance patient’s access tothe world’s most important imaging technologies and likely increases the diagnostic accuracy for many high incidence conditions such as cardiovascular and pulmonary diseases, lung cancer and osteoporosis. The last two decades have seen a transformation in radiology as detectors have evolved from film to digital semiconductor based devices. The next transformation will see the source switching from a single high dose acquisition to multiple very low dose acquisitions from distributed points so that more information (including 3D) can be gained from less dose. Among other benefits, the ongoing technological transformation of radiology will bring about significant cost savings. Current X-ray equipment requires a choice between high-cost 3D or lower-cost (but still expensive) 2D. All are large bulky solutions. Some are ‘moveable’ rather than truly portable. Low-cost truly portable systems based on Adaptix’ technology will allow clinicians to have easy access to 3D imaging information which can enhance the diagnostic information and likely impact patient care. Adaptix will transform radiology with its development of new Flat Panel X-ray source, a pixelated array made in a semiconductor foundry. Adaptix is harnessing a range of existing technologies, including from the space industry, and has patents filed and in process relating to both hardware and software. Companies using Adaptix products will offer 3D imaging at lower dose from smaller and lower-cost X-ray solutions. | $2.1M / Jan 15, 2019 | |
LIGNIA Wood Company
|
LIGNIA is the company is helping to tackle issues around the limited supplies of legal and sustainable hardwoods | $3.9M / Oct 10, 2018 | |
|
LIGNIA Wood Company
|
LIGNIA is the company is helping to tackle issues around the limited supplies of legal and sustainable hardwoods | $9.8M / Sep 07, 2018 | |
ADC Biotechnology
|
ADC Bio is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer drugs. The technology signals faster, simpler and less costly development for an exciting new family of drugs. | $1.4M / Apr 25, 2018 | |
Destiny Pharma
|
Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products.Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling thedrug-resistant bacteria that are at the centre of a global healthcare crisis. | $24M / Post-IPO Equity / Dec 04, 2017 | |
|
Destiny Pharma
|
Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products.Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling thedrug-resistant bacteria that are at the centre of a global healthcare crisis. | $20M / Post-IPO Equity / Oct 04, 2017 | |
KAO Data
|
Kao Data creates and manages high-performance data centers for advanced computing. We give enterprise, cloud, HPC, and AI customers with a world-class home for their computation with hyperscale-inspired facilities east and west of London. | $43.2M / Debt Financing / Feb 09, 2017 | |
Goonhilly Earth Station
|
Goonhilly Earth Station is a satellite communication teleport that provides telecommunication services. It offers satellite antenna services, including satellite communications teleport, satellite tracking and telemetry, earth station verification and assistance, launch and early operations support, very small aperture terminals, deep spacecommunications, and radio astronomy services. | $5M / Mar 20, 2014 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Downing LLP invest in?
Downing LLP invests primarily in Health Care, Data Center and Biotechnology startups, most often at Funding Round and Seed stage. Most of the 11 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Downing LLP?
Public channels for Downing LLP include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Downing LLP?
The team at Downing LLP includes Dan Quin (Head of Institutional Solutions), James Weaver (Deputy CEO & COO) and Linda Bell (Non-Executive Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
